bcbsil glp-1 coverage for obesity treatment in 13 US states' Medicaid programs Doctors call Ozempic a miracle

Ozempic and Rybelsus are FDA approved for people with Diabetes Type -2

52 Following 24-h incubation, the cells were transferred to Costa microtiter plates (150,000 cells/well, PerkinElmer) to achieve a 5%10% specific binding

[DOI] [PubMed] [Google Scholar] 265.Wadden T.A., et al

This was a study published in the New England Journal of Medicine, October 2024, One Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. Knee osteoarthritis is seen in 20% of those over the age of 45

"Pharmacy is the fastest-growing cost component of the MMI in 2026, rising 14.8% year-over-year for the average person," the Milliman analysis, which estimated prescription drug costs at 13% of total 2026 family health spending, or $4,700

Similarly, you have to keep taking GLP-1s to treat obesity